Σοφ. Βενιζέλου 114, Χαλάνδρι - Τ.: 2106719422
Study suggests risk of type 2 diabetes is as much as 50% higher after COVID-19 infection Rod Tucker 31 March, 2022 Infection with COVID-19 increases the risk of type 2 diabetes by 50% compared to other acute upper respiratory tract infections The type 2 diabetes risk after an acute infection with COVID-19 is as much…
Study suggests risk of type 2 diabetes is as much as 50% higher after COVID-19 infection Rod Tucker 31 March, 2022 Infection with COVID-19 increases the risk of type 2 diabetes by 50% compared to other acute upper respiratory tract infections The type 2 diabetes risk after an acute infection with COVID-19 is as much…
Depression risk greatly reduced even by low levels of physical activity Rod Tucker 21 April, 2022 The depression risk can be greatly reduced by undertaking low levels of physical activity according to a recent systematic review The risk of depression can be greatly reduced even by undertaking lower amounts of the recommended levels of physical…
Fish diet best for reducing risk of developing type 2 diabetes Rod Tucker 27 April, 2022 A fish diet rather than any other type of diet appears to be associated with the greatest reduction in the risk of developing type 2 diabetes A fish diet appears to be the best way of reducing the risk…
Higher avocado intake linked with a reduced risk of cardiovascular disease Rod Tucker 27 April, 2022 large amount (71%) of monounsaturated fatty acids and helps to promote healthy blood lipid profiles, enhancing the bioavailability of fat soluble vitamins and phyto-chemicals from the avocado or other fruits and vegetables. In fact, there are data showing how…
Study suggests risk of type 2 diabetes is as much as 50% higher after COVID-19 infection Rod Tucker 31 March, 2022 Infection with COVID-19 increases the risk of type 2 diabetes by 50% compared to other acute upper respiratory tract infections The type 2 diabetes risk after an acute infection with COVID-19 is as much…
Risk of clotting disorders higher after COVID-19 than vaccination Rod Tucker 27 August, 2021 A study suggests that the risk of clotting disorders appears to be significantly higher with COVID-19 infection compared to vaccination.
Higher levels of UVA associated with lower COVID-19 mortality Rod Tucker 12 April, 2021 Vitamin D is produced by the action of UVB on the skin, and while controversy remains over its role in COVID-19, UVA radiation might play a more important role. Solar radiation is significantly associated with the onset of epidemics of infectious…
Vaccination leads to higher T cell response in those previously infected with COVID-19 Rod Tucker 1 April, 2021
od Tucker 1 April, 2021 With high rates of vaccination across the UK, the latest ONS data suggests that 1 in 2 people have COVID-19 antibodies. The Office for National Statistics (ONS) has been examining trends in the rate of infection with COVID-19 across the UK and separately, the proportion of individuals who have detectable…
Four COVID Vaccines Compared WebMD News Staff February 05, 2021 ADD TO EMAIL ALERTS Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two COVID vaccines have already been approved for use in the United States and two more could be approved within the next few months. Here’s what we know about each…
Hospital Healthcare Europe 2 February, 2021 Mitochondrial DNA is inflammatory nucleic acids released by damaged organs and could represent a potentially useful marker for the identification of patients who develop more severe COVID-19 infection.
Yes. Due to the severe health risks associated with COVID-19 and the fact that re-infection with COVID-19 is possible, vaccine should be offered to you regardless of whether you already had COVID-19 infection. CDC is providing recommendations to federal, state, and local governments about who should be vaccinated first. At this time, experts do not…
Yes. COVID-19 vaccination works by teaching your immune system how to recognize and fight the virus that causes COVID-19, and this protects you from getting sick with COVID-19. Being protected from getting sick is important because even though many people with COVID-19 have only a mild illness, others may get a severe illness, have long-term health…
Yes. People who want to get pregnant in the future may receive the COVID-19 vaccine. Based on current knowledge, experts believe that COVID-19 vaccines are unlikely to pose a risk to a person trying to become pregnant in the short or long term. Scientists study every vaccine carefully for side effects immediately and for years…
No. COVID-19 mRNA vaccines do not change or interact with your DNA in any way. Messenger RNA vaccines—also called mRNA vaccines—are the first COVID-19 vaccines authorized for use in the United States. mRNA vaccines teach our cells how to make a protein that triggers an immune response. The mRNA from a COVID-19 vaccine never enters…
No. Neither the recently authorized and recommended vaccines nor the other COVID-19 vaccines currently in clinical trials in the United States can cause you to test positive on viral tests, which are used to see if you have a current infection. If your body develops an immune response—the goal of vaccination—there is a possibility you may test…
No. None of the authorized and recommended COVID-19 vaccines or COVID-19 vaccines currently in development in the United States contain the live virus that causes COVID-19. This means that a COVID-19 vaccine cannot make you sick with COVID-19. There are several different types of vaccines in development. All of them teach our immune systems how to recognize…
n a small-scale study, researchers from the Department of Biochemistry and Molecular Biology, University of Texas, US, have tested antibodies generated by 20 patients given the BNT162b2 (i.e., the Pfizer vaccine) against a laboratory-developed isogenic COVID-19 variant that contained mutations in the N501 and Y501 regions and which is similar to the South African variant.…
Παρακολουθώντας την διεξαγωγή διαδικτυακού συνεδρίου που έλαβε χώρα στην Βοστώνη στο πλαίσιο του Cardiometabolic health congress με συντονιστή τον Καθηγητή της Ιατρικής Σχολής Βοστώνης κύριο Χρήστο Μαντζώρο ,φάνηκε ποσο σημαντικό ειναι η διερεύνηση της ηπατικής συμμετοχής σε άτομα που πάσχουν απο σακχαρώδη διαβήτη τύπου 2,πολυκυστικές ωοθήκες ,αντίσταση στην ινσουλίνη, παχυσαρκία σε σχέση με την ανάπτυξη…
6 Devastating Plagues Take a look back at six of the most infamous outbreaks of the disease once known as the “Great Mortality.”Evan Andrews
Το Θεραπευτήριο Χρονίων Παθήσεων Δυτ. Αθήνας είναι μια μονάδα φιλοξενίας 160 περίπου ατόμων το οποίο ανήκει στο Κέντρο Κοινωνικής Πρόνοιας Περιφέρειας Αττικής και εποπτεύεται από το Υπουργείο Εργασίας. Η ιστορία του ιδρύματος αρχίζει το 1900 με το όνομα Κάνθαρος,πρώην στρατόπεδο,και στην συνέχεια αντιλεπρικός σταθμός ,τμήμα του Νοσοκομείου Λοιμωδών.Εκείνη την εποχή,επι Ελ. Βενιζέλου, είχαν προταθεί και…
Hospital Healthcare Europe 7 December, 2020
The highly anticipated vaccine (AZD1222) produced by a collaboration between Oxford University and AstraZeneca has become the first to have its interim study data published and appears to be as effective as reported in various media outlets. Findings A total of 23,848 patients were recruited across the 4 trials and 11,636 were included in the…
The Society for Maternal-Fetal Medicine recommends that pregnant and lactating women have access to COVID-19 vaccines in general and has advocated for the inclusion of women who are pregnant or lactating in vaccine trials. The society has suggested that health care professionals “counsel their patients that the theoretical risk of fetal harm from mRNA vaccines is…
Both Moderna’s vaccine — developed in collaboration with the U.S. National Institutes of Health — and Pfizer’s exceeded expectations in clinical trials. The comparable results are likely because the pair of COVID-19 vaccines are “a lot more alike than they are different,” says Susanna Naggie, an infectious disease physician at Duke University. “I think that’s…
Hospital Healthcare Europe 7 December, 2020 During the COVID-19 pandemic, sales of nutritional supplements known to have an important role in immune function such as vitamins C, D and the mineral, zinc, increased substantially. However, to date, no trials have shown evidence for a beneficial role of these supplements in COVID-19.
individuals experiencing a current episode of major depressive disorder (MDD) are significantly more likely to have insulin resistance (IR), new research shows. Investigators found patients with MDD were 51% more likely to have IR compared with their counterparts without the depressive disorder. In addition, in individuals experiencing current depression, IR was also associated with depression…
Women with type 2 diabetes who take metformin during pregnancy to control their blood glucose levels experience a range of benefits, including reduced weight gain, reduced insulin doses, and fewer large for gestational age babies, suggest the results of a randomized controlled trial.
With the onset of influenza season and the potential overlap of influenza and COVID-19 symptoms, there is a need to be able to quickly differentiate between the two viruses to ensure that patients are appropriately managed.
Sotagliflozin, a novel type of sodium-glucose cotransporter inhibitor, showed the diverse benefits this drug class provides along with some new twists in a pair of international pivotal trials that together enrolled nearly 12,000 patients with type 2 diabetes
Caption: Illustration showing a blood vessel with a platelet clot (yellow). Red blood cells (red), neutrophils (purple), and Y-shaped antibodies called aPL (white) circulate through the vessel. Credit: Stephanie King/Michigan Medicine For people with severe COVID-19, one of the most troubling complications is abnormal blood clotting that puts them at risk of having a debilitating…
More than 8 million people in the United States have now tested positive for COVID-19. For those who’ve recovered, many wonder if fending off SARS-CoV-2—the coronavirus that causes COVID-19—one time means their immune systems will protect them from reinfection. And, if so, how long will this “acquired immunity” last? The early data brought hope that…
Ορισμοί κρούσματος COVID -19 και «επαφών» κρούσματος COVID -19 Κλινικά κριτήρια Ασθενής με ένα τουλάχιστον από τα κατωτέρω συμπτώματα [1]: βήχας πυρετός δύσπνοια αιφνίδια εκδήλωση ανοσμίας, αγευσίας ή δυσγευσίας Απεικονιστικά διαγνωστικά κριτήρια Ακτινολογικά ευρήματα συμβατά με COVID-19 Εργαστηριακά κριτήρια Ανίχνευση νουκλεϊκού οξέος SARS-CoV-2 σε κλινικό δείγμα Επιδημιολογικά κριτήρια Τουλάχιστον ένα από τα κατωτέρω επιδημιολογικά κριτήρια: στενή…
ΣΤΡΑΤΗΓΙΚΗ ΛΗΞΗΣ ΚΑΡΑΝΤΙΝΑΣ ΚΑΙ ΑΠΟΜΟΝΩΣΗΣ ΣΤΕΝΩΝ ΕΠΑΦΩΝ & ΚΡΟΥΣΜΑΤΩΝ COVID19 Στο πλαίσιο της συνεχιζόμενης διασποράς του SARS-CoV-2, αυξάνοντας την ικανότητα ελέγχου σε διεθνές επίπεδο, και συγκεντρώνοντας στοιχεία σχετικά με την αποβολή του ιού και τη μολυσματικότητα του, υπάρχει ανάγκη επικαιροποίησης των οδηγιών για τον τερματισμό της απομόνωσης ατόμων με COVID-19. Οι οδηγίες αντικατοπτρίζουν τις διαθέσιμες…
Reuters) – People infected with COVID-19 develop antibodies targeting the new coronavirus that last for at least three months, according to two reports in Science Immunology. The two studies, together involving nearly 750 patients, both point to immunoglobulin G (IgG) antibodies as the longest-lasting. Researchers found IgG antibodies with two targets – the spike protein…
In our study, the neutralizing antibody titer correlated with the severity of the disease. This result suggests that patients with more severe disease might be more protected against reinfection and those with asymptomatic or mild disease could be more vulnerable to waning immunity over time because the initial immune response was not as strong as…
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Most SARS-CoV-2 virus strains feature a specific mutation that makes them more transmissible, to the point that these strains now predominate globally, new evidence shows. In contrast to a greater variety of strains early in the pandemic, now 99.9% of circulating SARS-CoV-2 strains in…
WPBakery Page Builder FDA Grants Emergency Use Authorization to Lilly’s Antibody COVID-19 Therapy Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) on Monday for the investigational monoclonal antibody therapy bamlanivimab (Eli Lilly) to…
Medscape Medical News November 5, 2020 Among patients with COVID-19 in ICU, increasing BMI was linked to worse pneumonia, need for mechanical ventilation, and severe obesity was tied to early death, in a new large international study.